Sebastien Duval

SynteractHCR is a full-service contract research organization, 900 employees, with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. Pperating in 16 countries, SynteractHCR delivers trials internationally, offering expertise across multiple therapeutic areas

Head of Business Development Phase II-IV Sales Team - USA, Europe & Asia - Development and execution of sales plans and strategies for QPS clinical phase II-IV key accounts QPS is a global GLP/GCP-compliant service provider to the pharmaceutical and biotechnology industry. 1300 employees.

Clinical Research: Phase 2-4 Reporting to CEO - Head of EU Business Development Sales Team - 13 countries - Development and execution of sales plans and strategies for Premier Research clinical phase 1-4 key accounts

Preclinical Research Reporting to CEO Full Service Toxicology, Safety and Health Research, 350 people - Head of USA & EU Business Development Sales & proposal Team (10 people) - Strategic responsibility for global pre-clinical sales & for setting and aligning / tracking sales goals, sales plans for Europe / USA

Clinical Research: Phase 1 & Bioanalysis Reporting to Senior Director & Site Manager - Head of USA & EU Business Development Sales & proposal Team (3 people)

Clinical Research: Phase 2-4 Head of Business Development Western Europe - Head of EU Business Development Sales Team - 5 countries (excluding UK, 8 BD Managers) - Development and execution of sales plans and strategies for Chiltern clinical phase 1-4 key accounts

Drug Discovery & hit-to-lead development From combinatorial chemistry to high throughput screening (HTS) & high throughput profiling (HTP) Business Development Manager South Europe (Spain, Italy & France)

Clinical Research: Phase 2-4, France Head of Business Development France

Business & Finance